|
Volumn 10, Issue 5, 2012, Pages 324-325
|
Regorafenib in metastatic colorectal cancer
a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBANILAMIDE DERIVATIVE;
PYRIDINE DERIVATIVE;
REGORAFENIB;
COLORECTAL NEOPLASMS;
HUMAN;
METASTASIS;
METHODOLOGY;
PALLIATIVE THERAPY;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL (TOPIC);
RESEARCH;
TREATMENT OUTCOME;
TRENDS;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS, PHASE III AS TOPIC;
COLORECTAL NEOPLASMS;
HUMANS;
NEOPLASM METASTASIS;
PALLIATIVE CARE;
PHENYLUREA COMPOUNDS;
PYRIDINES;
RESEARCH;
RESEARCH DESIGN;
TREATMENT OUTCOME;
|
EID: 84874633149
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (0)
|